TRIPs impact on R&D: Facts, facets and implications for Indian pharma industry

TRIPs impact on R&D: Facts, facets and implications for Indian pharma industry
The post-TRIPs scenario offers a viable option in terms of partnerships with MNCs, which indigenous firms need to capitalise upon, say Mohd. Arif Khan, Imran Parvez, Anand Sharma and Parikshit Bansal